Total Payments
$257,830
2024 Payments
$8,601
Companies
16
Transactions
385
Medicare Patients
4,295
Medicare Billing
$403,473
Payment Breakdown by Category
Other$218,081 (84.6%)
Travel$24,500 (9.5%)
Food & Beverage$8,593 (3.3%)
Consulting$6,630 (2.6%)
Education$26.03 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $218,069 | 130 | 84.6% |
| Travel and Lodging | $24,500 | 107 | 9.5% |
| Food and Beverage | $8,593 | 139 | 3.3% |
| Consulting Fee | $6,630 | 6 | 2.6% |
| Education | $26.03 | 2 | 0.0% |
| Entertainment | $12.48 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $197,662 | 283 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $43,430 | 42 | $0 (2019) |
| Regeneron Healthcare Solutions, Inc. | $8,920 | 11 | $0 (2019) |
| Abbott Laboratories | $6,967 | 13 | $0 (2019) |
| ATRICURE, INC. | $189.91 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $180.20 | 12 | $0 (2024) |
| Kaneka Pharma America LLC | $112.37 | 1 | $0 (2019) |
| AGEPHA Pharma FZ LLC | $83.75 | 1 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $66.38 | 4 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $48.04 | 3 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,601 | 18 | Amgen Inc. ($8,486) |
| 2023 | $9,007 | 19 | Amgen Inc. ($8,922) |
| 2022 | $11,990 | 20 | Amgen Inc. ($11,779) |
| 2021 | $11,150 | 14 | Amgen Inc. ($11,132) |
| 2020 | $7,223 | 12 | Amgen Inc. ($7,188) |
| 2019 | $42,099 | 59 | Amgen Inc. ($31,001) |
| 2018 | $38,105 | 59 | Amgen Inc. ($31,222) |
| 2017 | $129,655 | 184 | Amgen Inc. ($87,933) |
All Payment Transactions
385 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $33.00 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $18.76 | General |
| Category: Cardiology | ||||||
| 12/03/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $6.00 | General |
| Category: Cardiology | ||||||
| 11/14/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $128.32 | General |
| Category: Cardiology | ||||||
| 10/24/2024 | Boston Scientific Corporation | BodyGuardian (Device) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: CDS - BG Mini_RM | ||||||
| 09/10/2024 | AGEPHA Pharma FZ LLC | LODOCO (Drug) | Food and Beverage | In-kind items and services | $83.75 | General |
| Category: Cardiovascular Diseases | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.23 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/02/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: Cardiology | ||||||
| 05/31/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $99.23 | General |
| Category: Cardiology | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $7.37 | General |
| Category: Cardiology | ||||||
| 03/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $128.59 | General |
| Category: Cardiology | ||||||
| 02/14/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 02/14/2024 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $417.00 | General |
| Category: Cardiology | ||||||
| 02/13/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $36.85 | General |
| Category: Cardiology | ||||||
| 02/13/2024 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Cardiology | ||||||
| 02/07/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $89.25 | General |
| Category: Cardiology | ||||||
| 12/13/2023 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 12/12/2023 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $5.00 | General |
| Category: Cardiology | ||||||
| 12/12/2023 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $4.26 | General |
| Category: Cardiology | ||||||
| 12/04/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.73 | General |
| Category: Cardiology | ||||||
| 11/16/2023 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,500.00 | General |
| Category: Cardiology | ||||||
| 11/16/2023 | Amgen Inc. | Repatha (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $417.00 | General |
| Category: Cardiology | ||||||
| 11/15/2023 | Amgen Inc. | Repatha (Biological) | Travel and Lodging | Cash or cash equivalent | $70.74 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,111 | 1,681 | $428,969 | $100,456 |
| 2022 | 8 | 1,069 | 1,670 | $437,600 | $101,866 |
| 2021 | 8 | 1,053 | 1,601 | $422,006 | $104,169 |
| 2020 | 11 | 1,062 | 1,641 | $328,216 | $96,982 |
Total Patients
4,295
Total Services
6,593
Medicare Billing
$403,473
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 493 | 794 | $317,600 | $79,868 | 25.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 505 | 772 | $64,076 | $9,174 | 14.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 45 | 45 | $23,805 | $5,050 | 21.2% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 26 | $11,700 | $2,816 | 24.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 18 | $8,100 | $2,523 | 31.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 11 | $2,563 | $726.63 | 28.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 15 | 15 | $1,125 | $298.05 | 26.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 462 | 768 | $318,120 | $77,119 | 24.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 479 | 766 | $63,578 | $8,928 | 14.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 37 | 42 | $18,033 | $5,824 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $16,253 | $4,173 | 25.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $9,566 | $2,716 | 28.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 22 | 25 | $5,825 | $1,512 | 26.0% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $5,400 | $1,377 | 25.5% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2022 | 11 | 11 | $825.00 | $217.18 | 26.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 415 | 691 | $284,630 | $70,662 | 24.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 71 | 75 | $29,450 | $11,208 | 38.1% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 438 | 705 | $57,513 | $8,616 | 15.0% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 58 | 58 | $26,100 | $6,761 | 25.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 19 | 19 | $10,709 | $3,473 | 32.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $6,700 | $1,746 | 26.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 24 | 25 | $5,825 | $1,544 | 26.5% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2021 | 13 | 13 | $1,079 | $159.00 | 14.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 439 | 751 | $211,031 | $66,140 | 31.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 439 | 699 | $53,823 | $9,739 | 18.1% |
About Dr. Perry Weinstock, M.D
Dr. Perry Weinstock, M.D is a Cardiovascular Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841396009.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Perry Weinstock, M.D has received a total of $257,830 in payments from pharmaceutical and medical device companies, with $8,601 received in 2024. These payments were reported across 385 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($218,069).
As a Medicare-enrolled provider, Weinstock has provided services to 4,295 Medicare beneficiaries, totaling 6,593 services with total Medicare billing of $403,473. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease
- Location Camden, NJ
- Active Since 09/15/2006
- Last Updated 04/25/2016
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1841396009
Products in Payments
- Repatha (Biological) $197,405
- PRALUENT (Drug) $43,430
- PRALUENT ALIROCUMAB INJECTION (Biological) $7,722
- Ablation Therapy Hardware (Device) $3,978
- Ensite Cardiac Mapping System (Device) $2,730
- PRALUENT (Biological) $1,198
- Corlanor (Drug) $246.97
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX (Device) $189.91
- HeartMate (Device) $141.31
- ENTRESTO (Drug) $132.32
- LODOCO (Drug) $83.75
- XARELTO (Drug) $66.38
- Connectivity and Remote care (Device) $63.18
- ELIQUIS (Drug) $52.19
- Alere i (Device) $50.24
- LifeVest (Device) $48.04
- LEQVIO (Drug) $47.88
- Circulatory Support (Device) $29.52
- KYNAMRO (Drug) $18.53
- JUXTAPID (Drug) $18.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Camden
Mubashar Khan, M.d, M.D
Cardiovascular Disease — Payments: $33,373
Cardiovascular Disease $33,373
Zoltan Turi, Md, MD
Cardiovascular Disease — Payments: $28,055
Cardiovascular Disease $28,055
Dr. Devinder Singh, M.d, M.D
Cardiovascular Disease — Payments: $21,241
Cardiovascular Disease $21,241
Dr. Brian Corbett, D.o, D.O
Cardiovascular Disease — Payments: $16,931
Cardiovascular Disease $16,931
Kathleen Heintz, Do, DO
Cardiovascular Disease — Payments: $10,143
Cardiovascular Disease $10,143
Dr. Matthew Ortman, M.d, M.D
Cardiovascular Disease — Payments: $9,897
Cardiovascular Disease $9,897